Trial Profile
Lacunar-Brain Infarction Cerebral Hyperactivity And Atorvastatin Trial. A Placebo-Controlled Trial Of High-Dose Atorvastatin In Patients With Cerebral Small Vessel Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Cerebrovascular disorders; Stroke
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms LA-BICHAT
- Sponsors Pfizer
- 22 May 2009 New trial record.
- 01 May 2009 Results of reported in Stroke.